Name: Xin Weisheng
Address: 5995 Huyi Road, Shanghai, AB 123C, China
Telephone: 021 5958 5480
Price range: Competitive

21 Jun 2024

Biovac, EuBiologics partner to boost Africa meningitis vaccine

South African biopharmaceutical manufacturer, Biovac, has signed a technology transfer agreement with global South Korean based manufacturer EuBiologics, for the technology transfer of a Meningococcal Meningitis pentavalent conjugate vaccine.
Find out more
27 May 2024

Tackling Manufacturing Failures for Viral Vectors

A company founded last year is hoping to tackle a major problem in gene therapy—the failure of therapies to reach the marketplace due to production failures.
Find out more
10 Apr 2024

Generic lomustine to be first product of US-based partnership

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to produce lomustine, which is used to treat brain tumors.
Find out more
20 Mar 2024

Novo Invests $556M in China Operations to Boost Manufacturing Capacity

Novo Nordisk is investing approximately $556 million, or ¥4 billion, in a sterile preparations expansion project in its facility in China’s Tianjin city, the Danish drugmaker announced Tuesday in a Chinese-language announcement.
Find out more
27 Feb 2024

Alcami Grows Drug Testing Footprint In Wilmington

North Carolina pharmaceutical company Alcami Corporation has doubled its stability storage capability in Wilmington.
Find out more
31 Jan 2024

AbbVie pumps $223M into Singapore biologics plant, plots 100 hires

In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. Now, a little more than a year later, AbbVie is getting in on the action by starting a major production expansion in the Ga
Find out more
15 Jan 2024

Boehringer Ingelheim Expands Facility in Greece for Production of New Therapeutics

On Jan. 11, 2024, Boehringer Ingelheim announced that it is investing €120 million (US$131 million) to further expand and upgrade its production facility in Koropi, Greece. With the investment, the company plans to increase manufacturing capacity of new a
Find out more
09 Jan 2024

WuXi Biologics plans to expand manufacturing capacity at The Reactory

A Chinese pharmaceutical firm that is looking to make The Reactory life sciences park off Belmont Street its home will expand its drug manufacturing capacity by 50%, according to the company.
Find out more
25 Dec 2023

CDMO expands ADC facility in Scotland

Contract development and manufacturing organisation, Piramal Pharma Solutions, has expanded its antibody drug conjugate manufacturing facility in Scotland.
Find out more

News